Continental Advisors LLC Decreases Position in Hologic, Inc. (HOLX)

Continental Advisors LLC reduced its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 47.0% during the first quarter, Holdings Channel reports. The fund owned 30,100 shares of the medical equipment provider’s stock after selling 26,700 shares during the period. Continental Advisors LLC’s holdings in Hologic were worth $1,281,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in HOLX. KCG Holdings Inc. increased its stake in Hologic by 1.3% in the first quarter. KCG Holdings Inc. now owns 31,705 shares of the medical equipment provider’s stock valued at $1,349,000 after buying an additional 422 shares in the last quarter. Miles Capital Inc. acquired a new stake in Hologic during the first quarter valued at about $206,000. Next Century Growth Investors LLC acquired a new stake in Hologic during the first quarter valued at about $1,839,000. Geode Capital Management LLC increased its stake in Hologic by 6.4% in the first quarter. Geode Capital Management LLC now owns 3,116,366 shares of the medical equipment provider’s stock valued at $132,440,000 after buying an additional 186,854 shares in the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. increased its stake in Hologic by 2.2% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 12,647 shares of the medical equipment provider’s stock valued at $538,000 after buying an additional 270 shares in the last quarter. Hedge funds and other institutional investors own 94.47% of the company’s stock.

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Hologic, Inc. (NASDAQ HOLX) traded up 1.29% on Tuesday, hitting $45.60. 1,896,476 shares of the stock were exchanged. The company has a market cap of $12.77 billion, a P/E ratio of 16.35 and a beta of 0.94. Hologic, Inc. has a one year low of $32.81 and a one year high of $46.05. The company’s 50 day moving average price is $44.24 and its 200-day moving average price is $41.85.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings data on Wednesday, May 10th. The medical equipment provider reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.04. The business had revenue of $715.40 million for the quarter, compared to the consensus estimate of $685.24 million. Hologic had a net margin of 27.31% and a return on equity of 25.26%. Hologic’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the company posted $0.47 earnings per share. Equities research analysts predict that Hologic, Inc. will post $2.01 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Continental Advisors LLC Decreases Position in Hologic, Inc. (HOLX)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.tickerreport.com/banking-finance/2656334/continental-advisors-llc-decreases-position-in-hologic-inc-holx.html.

Several equities research analysts have issued reports on HOLX shares. BTIG Research reiterated a “buy” rating and set a $47.00 price objective on shares of Hologic in a research note on Sunday, May 14th. Stifel Nicolaus boosted their price objective on shares of Hologic from $45.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, May 11th. Canaccord Genuity reiterated a “buy” rating and set a $53.00 price objective on shares of Hologic in a research note on Tuesday, May 9th. Barclays PLC set a $50.00 price objective on shares of Hologic and gave the stock a “buy” rating in a research note on Wednesday, April 5th. Finally, Needham & Company LLC boosted their price objective on shares of Hologic from $46.00 to $50.00 and gave the stock a “buy” rating in a research note on Tuesday, April 4th. Five equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Hologic currently has an average rating of “Buy” and an average price target of $47.54.

In other news, Director Lawrence M. Levy sold 2,960 shares of the firm’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $44.54, for a total value of $131,838.40. Following the sale, the director now owns 45,634 shares in the company, valued at $2,032,538.36. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Elaine Ullian sold 9,104 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $42.40, for a total transaction of $386,009.60. Following the completion of the sale, the director now owns 23,810 shares in the company, valued at approximately $1,009,544. The disclosure for this sale can be found here. In the last 90 days, insiders sold 118,252 shares of company stock worth $5,158,821. 0.79% of the stock is currently owned by corporate insiders.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:HOLX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.